Evidence mapPaperPMID 19592049Full record

ArticleMetabolism: clinical and experimental2009

The influence of sex, body composition, and nonesterified fatty acids on serum adipokine concentrations.

Eric P Plaisance, Peter W Grandjean, Robert L Judd, Kathy W Jones, J Kyle Taylor

Open access · greenAbstract read
In one paragraph

Article in Metabolism: clinical and experimental, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Clinical and Therapeutic Implications of Male Obesity.Journal of clinical medicine · 2023
    Review
  7. Article
  8. Article
  9. Fasting insulin reflects heterogeneous physiological processes: role of insulin clearance.American journal of physiology. Endocrinology and metabolism · 2011
    Article
  10. Article
  11. Effect of weight loss on adipokine levels in obese patients.Diabetes, metabolic syndrome and obesity : targets and therapy · 2011
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Eric P PlaisanceDepartment of Anatomy Physiology and Pharmacology, Auburn University-Montgomery, Montgomery, AL 36849, USA. plaisep@auburn.edu
Peter W Grandjean
Robert L Judd
Kathy W Jones
J Kyle Taylor
Auburn University at Montgomery · US

Funding

Pilot and Feasibility ProgramP30DK072476 · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · 2005 to 2025
$2.2M
Training in Obesity ResearchT32DK064584 · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · 2003 to 2025
$932k
NIDDK NIH HHS P30 DK072476
6 · The paper itself

Abstract

Serum adiponectin concentrations are higher in women than men. The sexual dimorphism for adiponectin has been attributed to the direct effects of testosterone on adipose tissue adiponectin secretion. However, serum testosterone and adiponectin concentrations are generally lower in obese men than lean men, suggesting that sex steroids may not be the only factor that contributes to sex differences in serum adiponectin. The primary objective of this study was to examine the influence of sex, body composition, and nonesterified fatty acids (NEFAs) on serum adiponectin concentrations. Women and men between the ages of 18 and 35 years were consecutively accrued into the study. Sixty-one participants were partitioned into normal-weight (15 female and 16 male) or obese (14 female and 16 male) groups. Blood samples were obtained after a 12-hour fast. Differences between groups were determined by analysis of variance with Tukey-Kramer post hoc testing. Serum adiponectin was 26% higher in women compared with men. Body mass index was associated with total serum adiponectin in men (r = -0.63, P < .05) but not women. Adiponectin was correlated with the homeostasis model assessment index in women (r = -0.56, P < .05) and men (r = -0.58, P < .05) and with NEFAs (r = -0.68, P < .05) in men only. After partitioning men and women into normal-weight and obese groups, serum adiponectin was lower and NEFAs were higher in obese men only. Homeostasis model assessment was similar between obese women and men despite higher NEFAs in the obese men. Leptin and plasminogen activator inhibitor-1 were higher in obese participants but were not associated with serum NEFAs. These results suggest that serum NEFAs may reduce adiponectin concentrations independent of their effects on insulin sensitivity in obese young men.

Indexed as

AdipokinesAdiponectinAdolescentAdultBody CompositionBody Mass IndexCohort StudiesFatty Acids, NonesterifiedFemaleHormonesHumansLipidsMaleObesityRisk FactorsSex CharacteristicsAdipokinesAdiponectinFatty Acids, NonesterifiedHormonesLipids

Identifiers

PMID19592049
PMCPMC7134378
OpenAlexW1990280336

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.